Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Independent Validation of the 2008 World Health Organization (WHO) Reclassification of Myelodysplastic Syndromes (MDS) Associated with Ring Sideroblasts

David P. Steensma, MD, FACP, Curtis A Hanson, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 2686.

https://doi.org/10.1182/blood.V112.11.2686.2686

Published: 2008

Journal Articles

Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution

Rafael Santana-Davila, MD, Shernan G. Holtan, MD, Rhett Ketterling, MD, Ryan A Knudson, David P. Steensma, MD, FACP, Dong Chen, MD, PhD, James Hoyer, MD, Curtis A Hanson, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 2523.

https://doi.org/10.1182/blood.V112.11.2523.2523

Published: 2008

Journal Articles

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

Julia Bohlius, MD, MScPH, Corinne Brillant, Michael Clarke, DPhil, Sabine Kluge, Maryann Napoli, Margaret Piper, PhD, MPH, Dirk Rades, MD, PhD, Martin Schumacher, PhD, Kurt Schmidlin, Guido Schwarzer, PhD, Jerome Seidenfeld, MSc, PhD, David P. Steensma, MD, FACP, Sven Trelle, Olaf Weingart, MD, Marcel Zwahlen, Matthias Egger, MD, MSc, Andreas Engert, MD

Blood (2008) 112 (11): 4675.

https://doi.org/10.1182/blood.V112.11.4675.4675

Published: 2008

Journal Articles

Assessment and Monitoring of Constitutional Symptoms in Patients with Myelofibrosis: A Proposed New Instrument the Myelofibrosis Symptom Assessment Form (MFSAF).

Ruben A. Mesa, MD, FACP, Susan Schwager, Deepti Radia, MD, Andrea Cheville, MD, Kebede Hussein, MD, Joyce Niblack, JD, Animesh D. Pardanani, MBBS, PhD, David P. Steensma, MD, FACP, Mark R. Litzow, MD, Candido E. Rivera, MD, John Camoriano, MD, Srdan Verstovsek, Jeffrey Sloan, PhD, Claire Harrison, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 1754.

https://doi.org/10.1182/blood.V112.11.1754.1754

Published: 2008

Journal Articles

Rearrangements of IER3 Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes (MDS)

David P. Steensma, MD, FACP, Jessemy D Neiger, MD, Julie C Porcher, MS, J. Jonathan Keats, PhD, Peter Leif Bergsagel, MD, Ryan A Knudson, Rafael Santana-Davila, MD, Rajiv Kumar, MD, Rhett Ketterling, MD

Blood (2008) 112 (11): 2679.

https://doi.org/10.1182/blood.V112.11.2679.2679

Published: 2008

Journal Articles

Low Absolute Lymphocyte Count (ALC) at Diagnosis Is An IPSS-Independent Predictor of Poorer Survival in Myelodysplastic Syndromes (MDS)

Nisha L Jacobs, Shernan G Holtan, MD, Luis F Porrata, MD, Svetomir N Markovic, MD, PhD, Ayalew Tefferi, MD, David P. Steensma, MD, FACP

Blood (2008) 112 (11): 3633.

https://doi.org/10.1182/blood.V112.11.3633.3633

Published: 2008

Journal Articles

Red Blood Cell Transfusion Requirement at Diagnosis Adversely Affects Both Overall and Leukemia-Free Survival in Primary Myelofibrosis - Increased Serum Ferritin or Total Transfusion Burden Does Not

Ayalew Tefferi, MD, Ruben A. Mesa, MD, FACP, Jocelin Huang, MD, Animesh D. Pardanani, MBBS, PhD, Kebede Hussein, MD, Susan Schwager, Curtis A. Hanson, David P. Steensma, MD, FACP

Blood (2008) 112 (11): 5232.

https://doi.org/10.1182/blood.V112.11.5232.5232

Published: 2008

Journal Articles

Extreme Leukocytosis in the 21st Century Is Often Iatrogenic

Zachary P. Hugo, MD, Michael C. Perry, MD, David P. Steensma, MD, FACP

Blood (2008) 112 (11): 5401.

https://doi.org/10.1182/blood.V112.11.5401.5401

Published: 2008

Journal Articles

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

Julia Bohlius, MD, MScPH, Corinne Brillant, Michael Clarke, PhD, Sabine Kluge, Maryann Napoli, Margaret Piper, PhD, MPH, Dirk Rades, MD, PhD, Isabelle Ray-Coquard, MD, Kurt Schmidlin, MD, MPH, Martin Schumacher, PhD, Guido Schwarzer, PhD, Jerome Seidenfeld, MSc, PhD, David P. Steensma, MD, FACP, Sven Trelle, MD, Michael Untch, MD, Olaf Weingart, MD, Marcel Zwahlen, PhD, Matthias Egger, MD, MSc, Andreas Engert, MD

Blood (2008) 112 (11): lba-6.

https://doi.org/10.1182/blood.V112.11.lba-6.lba-6

Published: 2008

NARROW

Independent Validation of the 2008 World Health Organization (WHO) Reclassification of Myelodysplastic Syndromes (MDS) Associated with Ring Sideroblasts

Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

Assessment and Monitoring of Constitutional Symptoms in Patients with Myelofibrosis: A Proposed New Instrument the Myelofibrosis Symptom Assessment Form (MFSAF).

Rearrangements of IER3 Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes (MDS)

Low Absolute Lymphocyte Count (ALC) at Diagnosis Is An IPSS-Independent Predictor of Poorer Survival in Myelodysplastic Syndromes (MDS)

Red Blood Cell Transfusion Requirement at Diagnosis Adversely Affects Both Overall and Leukemia-Free Survival in Primary Myelofibrosis - Increased Serum Ferritin or Total Transfusion Burden Does Not

Extreme Leukocytosis in the 21st Century Is Often Iatrogenic

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only